Trial Details for COPD Study 224025
Description This study drug is being developed for the treatment of Chronic Obstructive Pulmonary Disease (COPD). COPD is a disease of the airways that causes inflammation and narrowing of the airways making it difficult to breathe.
Qualifiers Health Status: Healthy
Ages: 18 to 55
BMI Range: 18 to 30
Inconvenience Allowance Max Allowance: £3540
Screening Allowance: £0